Genetic analysis of ras mutation specificity in skin and lung cancer

皮肤癌和肺癌中ras突变特异性的遗传分析

基本信息

  • 批准号:
    9191353
  • 负责人:
  • 金额:
    $ 36.26万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-01-01 至 2017-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Activating mutations in genes of the RAS family are the most common dominant acting oncogenic changes in human cancers. These tumors are particularly difficult to treat, and have a very poor prognosis. Mutations in RAS family members exhibit tissue specificity, but we do not know how tissue damage, inflammation and the resultant remodeling process results in early selection of cells carrying specific mutations in individual RAS isoforms. Mutations in the HRAS gene are mainly found in squamous carcinomas (SCCs) of the lung, skin, and head and neck, which share many histological and molecular characteristics and together constitute a major human cancer burden worldwide. In contrast, KRAS is the most commonly mutated oncogene in adenocarcinomas of the lung, pancreas, and colon. The same tissue specificity is observed in mouse cancer models: carcinogen-induced squamous tumors of the skin have almost 100% Hras mutations, whereas lung adenocarcinomas induced by the same carcinogen have almost 100% Kras mutations. The identification of the factors that underlie this specificity would provide important information tht may lead to tissue-specific or mutation-specific routes to cancer prevention or treatment. We generated novel mouse models in which the specificity for particular Ras isoforms in skin and lung has been reversed or eliminated, resulting in mice that develop Kras mutant skin carcinomas, Hras mutant lung carcinomas, or are completely resistant to chemical carcinogen treatment. This project will exploit these novel mouse models as well as computational network approaches to the identification of functions of Ras genes in normal tissue and carcinomas driven by either Hras or Kras. Mouse gene expression network data will be validated in human samples by integration with human gene expression datasets from squamous carcinomas of the lung and head and neck (generated by TCGA) or in primary cutaneous SCCs, in particular with human SCCs from BRAF-inhibitor treated patients which have an elevated frequency of HRAS (Q61L) gene mutations - exactly the same point mutation that is found in Hras mutant mouse skin tumors. We will use a Systems Biology approach to visualize the architecture of Ras signaling in whole tissues in vivo and in epithelial cells derived from mutant mice, to examine the relationships between inflammation and susceptibility to development of Hras- or Kras-driven malignancies. This comprehensive systems-based approach will reveal conserved features of squamous carcinoma formation that will first help us to understand the genesis of these neoplasms, and begin to formulate strategies for prevention or treatment.
描述(由申请方提供):RAS家族基因中的激活突变是人类癌症中最常见的显性致癌变化。这些肿瘤特别难以治疗,并且预后非常差。RAS家族成员中的突变表现出组织特异性,但我们不知道组织损伤、炎症和由此产生的重塑过程如何导致早期选择携带单个RAS亚型中特定突变的细胞。HRAS基因的突变主要见于肺、皮肤和头颈部的鳞状细胞癌(SCC),它们具有许多共同的组织学和分子特征,共同构成了全球主要的人类癌症负担。相反,KRAS是肺、胰腺和结肠腺癌中最常见的突变癌基因。在小鼠癌症模型中观察到相同的组织特异性:致癌物诱导的皮肤鳞状肿瘤具有几乎100%的Hras突变,而由相同致癌物诱导的肺腺癌具有几乎100%的Kras突变。鉴定这种特异性的基础因素将提供重要的信息,可能导致组织特异性或突变特异性的癌症预防或治疗途径。我们产生了新的小鼠模型,其中皮肤和肺中特定Ras亚型的特异性被逆转或消除,导致小鼠发生Kras突变皮肤癌、Hras突变肺癌或对化学致癌物治疗完全耐受。该项目将利用这些新的小鼠模型以及计算网络方法来鉴定Ras基因在正常组织和由Hras或Kras驱动的癌症中的功能。将通过整合来自肺和头颈部鳞状细胞癌(由TCGA生成)或原发性皮肤SCC的人基因表达数据集,特别是来自BRAF抑制剂治疗患者的人SCC(HRAS(Q61 L)基因突变频率升高-与Hras突变小鼠皮肤肿瘤中发现的点突变完全相同),在人样本中验证小鼠基因表达网络数据。我们将使用系统生物学方法来可视化Ras信号传导在体内整个组织和突变小鼠上皮细胞中的结构,以检查炎症与Hras或Kras驱动的恶性肿瘤发生易感性之间的关系。这种全面的基于系统的方法将揭示鳞状细胞癌形成的保守特征,这将首先帮助我们了解这些肿瘤的起源,并开始制定预防或治疗策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALLAN BALMAIN其他文献

ALLAN BALMAIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALLAN BALMAIN', 18)}}的其他基金

PROMINENT - UCSF
杰出 - UCSF
  • 批准号:
    10845756
  • 财政年份:
    2022
  • 资助金额:
    $ 36.26万
  • 项目类别:
PROMINENT - UCSF
杰出 - UCSF
  • 批准号:
    10625150
  • 财政年份:
    2022
  • 资助金额:
    $ 36.26万
  • 项目类别:
Integrating targeted and immunotherapy to treat genetically heterogeneous cancers
整合靶向治疗和免疫治疗来治疗遗传异质性癌症
  • 批准号:
    10199951
  • 财政年份:
    2017
  • 资助金额:
    $ 36.26万
  • 项目类别:
Systems genetics analysis of tumor evolution in the mouse
小鼠肿瘤进化的系统遗传学分析
  • 批准号:
    10621723
  • 财政年份:
    2017
  • 资助金额:
    $ 36.26万
  • 项目类别:
Systems genetics analysis of tumor evolution in the mouse
小鼠肿瘤进化的系统遗传学分析
  • 批准号:
    10394264
  • 财政年份:
    2017
  • 资助金额:
    $ 36.26万
  • 项目类别:
Integrating targeted and immunotherapy to treat genetically heterogeneous cancers
整合靶向治疗和免疫治疗来治疗遗传异质性癌症
  • 批准号:
    9767561
  • 财政年份:
    2017
  • 资助金额:
    $ 36.26万
  • 项目类别:
Integrating targeted and immunotherapy to treat genetically heterogeneous cancers
整合靶向治疗和免疫治疗来治疗遗传异质性癌症
  • 批准号:
    9363115
  • 财政年份:
    2017
  • 资助金额:
    $ 36.26万
  • 项目类别:
The Oncogenic and Tumor Suppressor Functions of the Kras isoform 4A in vivo
Kras 亚型 4A 体内的致癌和抑癌功能
  • 批准号:
    8672543
  • 财政年份:
    2015
  • 资助金额:
    $ 36.26万
  • 项目类别:
The Oncogenic and Tumor Suppressor Functions of the Kras isoform 4A in vivo
Kras 亚型 4A 体内的致癌和抑癌功能
  • 批准号:
    9058497
  • 财政年份:
    2015
  • 资助金额:
    $ 36.26万
  • 项目类别:
Science Leadership and Integration
科学领导力与整合
  • 批准号:
    7923790
  • 财政年份:
    2009
  • 资助金额:
    $ 36.26万
  • 项目类别:

相似海外基金

CAREER: Efficient Algorithms for Modern Computer Architecture
职业:现代计算机架构的高效算法
  • 批准号:
    2339310
  • 财政年份:
    2024
  • 资助金额:
    $ 36.26万
  • 项目类别:
    Continuing Grant
CAREER: Creating Tough, Sustainable Materials Using Fracture Size-Effects and Architecture
职业:利用断裂尺寸效应和架构创造坚韧、可持续的材料
  • 批准号:
    2339197
  • 财政年份:
    2024
  • 资助金额:
    $ 36.26万
  • 项目类别:
    Standard Grant
Travel: Student Travel Support for the 51st International Symposium on Computer Architecture (ISCA)
旅行:第 51 届计算机体系结构国际研讨会 (ISCA) 的学生旅行支持
  • 批准号:
    2409279
  • 财政年份:
    2024
  • 资助金额:
    $ 36.26万
  • 项目类别:
    Standard Grant
Understanding Architecture Hierarchy of Polymer Networks to Control Mechanical Responses
了解聚合物网络的架构层次结构以控制机械响应
  • 批准号:
    2419386
  • 财政年份:
    2024
  • 资助金额:
    $ 36.26万
  • 项目类别:
    Standard Grant
I-Corps: Highly Scalable Differential Power Processing Architecture
I-Corps:高度可扩展的差分电源处理架构
  • 批准号:
    2348571
  • 财政年份:
    2024
  • 资助金额:
    $ 36.26万
  • 项目类别:
    Standard Grant
Collaborative Research: Merging Human Creativity with Computational Intelligence for the Design of Next Generation Responsive Architecture
协作研究:将人类创造力与计算智能相结合,设计下一代响应式架构
  • 批准号:
    2329759
  • 财政年份:
    2024
  • 资助金额:
    $ 36.26万
  • 项目类别:
    Standard Grant
Hardware-aware Network Architecture Search under ML Training workloads
ML 训练工作负载下的硬件感知网络架构搜索
  • 批准号:
    2904511
  • 财政年份:
    2024
  • 资助金额:
    $ 36.26万
  • 项目类别:
    Studentship
The architecture and evolution of host control in a microbial symbiosis
微生物共生中宿主控制的结构和进化
  • 批准号:
    BB/X014657/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.26万
  • 项目类别:
    Research Grant
NSF Convergence Accelerator Track M: Bio-Inspired Surface Design for High Performance Mechanical Tracking Solar Collection Skins in Architecture
NSF Convergence Accelerator Track M:建筑中高性能机械跟踪太阳能收集表皮的仿生表面设计
  • 批准号:
    2344424
  • 财政年份:
    2024
  • 资助金额:
    $ 36.26万
  • 项目类别:
    Standard Grant
RACCTURK: Rock-cut Architecture and Christian Communities in Turkey, from Antiquity to 1923
RACCTURK:土耳其的岩石建筑和基督教社区,从古代到 1923 年
  • 批准号:
    EP/Y028120/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.26万
  • 项目类别:
    Fellowship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了